BioVersys AG (BIOV)
SIX
25.30
+0.10 (+0.40%)
Closed
Aug 26, 2026
Day's Range
24.8025.30
52 wk Range
21.2033.90
Financial Statements - BIOV - BioVersys AG
Revenue
800.00K
Net Income
-21.83M▼ 16.6%Net Margin -2728.8%
EBITDA
-20.62M▼ 15.7%
Free Cash Flow
-22.16M▼ 42.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 800K | 0 |
| Cost of Goods | 3.89M | 3.94M |
| Gross Profit | -3.09M | -3.94M |
 Operating Expense | - | - |
| Operating Income | -19.96M | -18.72M |
| Non-Operating Interest | - | - |
| Other Income Expense | - | - |
| Pre Tax Income | -21.81M | -18.71M |
| Income Tax | 16K | 0 |
| Net Income | -21.83M | -18.71M |
| EPS Basic | -3.89 | -3.16493 |
| EPS Diluted | -3.89 | -3.16493 |
| Basic Shares Outstanding | 5.61M | 5.91M |
| Diluted Shares Outstanding | 5.61M | 5.91M |
| Ebit | -20.73M | -17.68M |
| Ebitda | -20.62M | -17.83M |
| Net Income Continuous Operations | -21.81M | -18.71M |
| Minority Interests | - | - |
| Preferred Stock Dividends | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
